Mirabegron safe and effective for NDO
Sign Up to like & getrecommendations! Published in 2021 at "Nature Reviews Urology"
DOI: 10.1038/s41585-021-00494-w
Abstract: Data have been reported from a baselinecontrolled, phase III study of mirabegron in children and adolescents (3–18 years) with neurogenic detrusor overactivity (NDO). Patients received mirabegron at an adult dose equivalent of 25 mg daily,… read more here.
Keywords: ndo; volume; effective ndo; mirabegron safe ... See more keywords